Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 57.78B | 59.47B | 50.49B | 41.92B | 42.43B | 30.52B |
Gross Profit | 20.12B | 20.83B | 17.56B | 14.21B | 13.49B | 7.38B |
EBITDA | 6.26B | 7.22B | 6.16B | 4.23B | 4.86B | 152.19M |
Net Income | 2.07B | 1.72B | 1.63B | 607.57M | 1.07B | -2.42B |
Balance Sheet | ||||||
Total Assets | 43.13B | 44.11B | 40.83B | 36.86B | 30.91B | 35.14B |
Cash, Cash Equivalents and Short-Term Investments | 4.55B | 3.79B | 4.33B | 2.75B | 3.58B | 3.82B |
Total Debt | 18.96B | 19.13B | 17.18B | 17.84B | 12.73B | 16.79B |
Total Liabilities | 31.38B | 32.10B | 29.94B | 27.38B | 22.00B | 27.36B |
Stockholders Equity | 11.19B | 11.43B | 10.43B | 9.12B | 8.61B | 7.56B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 637.00M | 3.46B | -5.25B | 4.19B | -3.11B |
Operating Cash Flow | 0.00 | 3.59B | 6.97B | -2.44B | 6.02B | -1.10B |
Investing Cash Flow | 0.00 | -4.84B | -4.20B | -3.06B | -1.90B | -2.17B |
Financing Cash Flow | 0.00 | 718.00M | -1.30B | 4.55B | -4.44B | 4.31B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | €193.81B | 10.53 | 15.38% | 1.17% | 0.31% | 23.47% | |
75 Outperform | ¥43.46B | 10.18 | 3.07% | 12.38% | 68.86% | ||
71 Outperform | ¥7.55B | 17.74 | 3.24% | -0.51% | 420.31% | ||
71 Outperform | ¥24.14B | 11.80 | 2.48% | 17.79% | 5.73% | ||
65 Neutral | ¥499.79B | 7.74 | ― | -9.17% | ― | ||
61 Neutral | $34.87B | 5.87 | -10.42% | 2.07% | 6.72% | -8.84% | |
57 Neutral | ¥84.30B | 24.28 | 2.55% | 0.31% | -50.17% |